ArticleCureus2025
Continuation of Pregnancy After Donor Twin Demise Following Fetoscopic Laser Photocoagulation to Treat Twin-Twin Transfusion Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monochorionic diamniotic (MCDA) pregnancy with eccentric cord insertion may lead to twin-twin transfusion syndrome (TTTS), which can be treated by fetoscopic laser photocoagulation (FLP). The procedure has its risks, including the demise of one or both twins. A 33-year-old primigravida woman with MCDA twins was diagnosed with TTTS and eccentric cord insertion at 18 weeks of gestation. FLP was performed, resulting in the demise of the donor twin. The surviving twin was later diagnosed with congenital pulmonary airway malformation and was delivered at 38 weeks with stable outcomes, while the papyraceous twin was delivered by manual extraction. This case discusses eccentric cord insertion as a possible cause of TTTS managed with FLP and its associated risks. It emphasizes the necessity for rigorous surveillance and timely interventions in high-risk pregnancies, showcasing the importance of a comprehensive care approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.